COGNITION THERAPEUTICS ($CGTX) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.14 per share, missing estimates of -$0.11 by $0.03. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $CGTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COGNITION THERAPEUTICS Insider Trading Activity
COGNITION THERAPEUTICS insiders have traded $CGTX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CGTX stock by insiders over the last 6 months:
- LISA RICCIARDI (CEO & President) purchased 38,851 shares for an estimated $30,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COGNITION THERAPEUTICS Hedge Fund Activity
We have seen 18 institutional investors add shares of COGNITION THERAPEUTICS stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VOSS CAPITAL, LP added 500,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $350,650
- UBS GROUP AG removed 156,747 shares (-79.2%) from their portfolio in Q4 2024, for an estimated $109,926
- STATE STREET CORP added 59,100 shares (+94.2%) to their portfolio in Q4 2024, for an estimated $41,446
- TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC removed 55,395 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $38,848
- CM MANAGEMENT, LLC removed 50,000 shares (-20.0%) from their portfolio in Q4 2024, for an estimated $35,065
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 44,826 shares (-58.4%) from their portfolio in Q4 2024, for an estimated $31,436
- TWO SIGMA INVESTMENTS, LP added 42,321 shares (+372.2%) to their portfolio in Q4 2024, for an estimated $29,679
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COGNITION THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $CGTX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley issued a "Buy" rating on 12/19/2024
- H.C. Wainwright issued a "Buy" rating on 12/19/2024
To track analyst ratings and price targets for COGNITION THERAPEUTICS, check out Quiver Quantitative's $CGTX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
